Developing Genome Editing Solutions for BTB
Oct 25 2018 Read 754 Times
A collaborative research project with the University College Dublin in the Republic of Ireland and Queen’s University Belfast in Northern Ireland to combat Mycobacterium bovis (M. bovis) infection, the pathogen that causes bovine tuberculosis (BTB), has been launched by US bio-engineering company Recombinetics.
A global threat to animal and human health and a major challenge to sustainable beef and dairy farming, M.bovis annually creates an estimated $3 billion in global losses to agriculture. The primary financial burden of BTB in developed countries is the control of infection, which is still detected sporadically despite disease eradication programs.
The project goals are to offer precision breeding solutions to improve existing BTB controls without the need for additional antibiotics or ineffective vaccines.
The team includes Drs. Tad S. Sonstegard and Daniel F. Carlson from Recombinetics in the US, who will lead the design and implementation of the genome editing protocol; Professors David E. MacHugh and Stephen V. Gordon from the College of Health and Agricultural Sciences at University College Dublin will lead the systematic identification and analysis of candidate target genes via in vitro challenge experiments in gene edited cells; and Drs. David A. Simpson and Andriana Margariti at the Centre for Experimental Medicine, Queen’s University Belfast, will lead the stem cell production effort.
The project is funded by the United States Department of Agriculture’s National Institute of Food Agriculture, the Department of Agriculture, Food and the Marine in the Irish Republic and Northern Ireland’s Department of Agriculture, Environment and Rural Affairs. It is part of the United States‒Ireland Research and Development Partnership Program that solicited collaborative research applications in the Animal Health and Disease programme area.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Spotlight Proteomics, Genomics & Microarrays - Enhanced NGS Analysis Software Launched - How to Create Robust, Viable Collagen Scaffolds - Differential Ion Mobility Inter...
View all digital editions
Nov 21 2018 Telford, UK
Dec 14 2018 Kathmandu, Nepal
Jan 16 2019 Tokyo, Japan
Jan 28 2019 Dubai International Convention & Exhibition Centre
Jan 30 2019 Tokyo, Japan